Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 6/20 | 0.34 |
| ▸ | HCRTR2 | O43614 | 6/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.31 |
| ▸ | CETP | P11597 | 2/20 | 0.31 |
| ▸ | OXTR | P30559 | 1/20 | 0.31 |
| ▸ | TACR3 | P29371 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
| ▸ | POLQ | O75417 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1421842 | 1.00 | HCRTR1 (0.34) | HCRTR1HCRTR2MEN1KMT2AFFAR1 | |
| SCHEMBL1422607 | 0.79 | GPBAR1 (0.34) | HCRTR1HCRTR2MEN1KMT2APOLQ | |
| SCHEMBL1422609 | 0.79 | GPBAR1 (0.34) | HCRTR1HCRTR2MEN1KMT2APOLQ | |
| SCHEMBL271747 | 0.79 | FFAR1 (0.37) | HCRTR1HCRTR2MEN1KMT2AFFAR1 | |
| SCHEMBL264910 | 0.79 | FFAR1 (0.37) | HCRTR1HCRTR2MEN1KMT2AFFAR1 | |
| SCHEMBL264909 | 0.79 | FFAR1 (0.37) | HCRTR1HCRTR2MEN1KMT2AFFAR1 | |
| SCHEMBL264248 | 0.79 | MEN1 (0.36) | HCRTR1HCRTR2MEN1KMT2ACETP | |
| SCHEMBL264249 | 0.79 | MEN1 (0.36) | HCRTR1HCRTR2MEN1KMT2ACETP | |
| SCHEMBL264250 | 0.79 | MEN1 (0.36) | HCRTR1HCRTR2MEN1KMT2ACETP | |
| SCHEMBL1422029 | 0.78 | POLQ (0.35) | HCRTR1HCRTR2POLQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2297102-A1 | HETEROAROMATIC MONOAMIDES AS OREXININ RECEPTOR ANTAGONISTS | F. Hoffmann-La Roche AG (CH) | 2011-03-23 | — | — | EP | disclosed |